Improvement of stage 1 hypertension by transcutaneous acupoint electrical stimulation based on mobile health: a randomized controlled pilot trial

Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Meet the diagnostic criteria for stage 1 hypertension;
•2. Age between 35 and 65 years old;
•3. No language and mental retardation, can successfully answer and fill out the questionnaire;
•4. Voluntary signing of informed consent.

•1. Contraindications for the use of acupoint stimulators: wearing a pacemaker and other implanted medical devices; suffering from acute diseases, infectious diseases, malignant tumors;cardiovascular disease, cerebrovascular disease, liver and kidney dysfunction or other malignant diseases; scars, bruises, scratches or inflammation on the skin of the acupuncture points.
•2. Hypertension caused by other vascular diseases, primary aldosteronism, other endocrine hypertension, and secondary hypertension caused by other causes.
•3. Receiving drugs that affect blood pressure except antihypertensive drugs in previous 2 months such as glucocorticoids, central nervous system inhibitors.
•4. Uncontrolled diabetes.
•5. Receiving acupuncture treatment in previous 1 month.
•6. Drug or alcohol abuse.
•7. Pregnant women or women in lactation period.
•8. Joined any other study in process.

发起方

Beijing University of Chinese Medicine